Search All News
Twenty years ago, Columbia scientists created a way to make neurons in a dish, a discovery that has led to clinical trials of an experimental drug that may slow the progression of ALS.
Using EEG to identify covert consciousness in unresponsive brain-injured patients could help predict which ones may recover, find researchers at Columbia and NewYork-Presbyterian.
- September 10, 2015
Researchers have discovered why long-term use of levodopa treatment commonly leads to a side effect that can be as debilitating as Parkinson’s disease itself.
- August 20, 2015
Biogen, the ALS Association, and Columbia University Medical Center have announced a new collaboration to better understand the differences and commonalities in the ALS disease process and how genes influence the clinical features of the disease.
- February 24, 2015
Three successful movies from this year's Oscars featured strong medicine and science narratives.
- January 5, 2015
Columbia’s neurology department launches new research division to study outcomes as more treatments become available to help neurological patients.
- December 22, 2014
People with autism have a wide range of symptoms, with no two people sharing the exact type and severity of behaviors. Now a large-scale analysis of hundreds of patients and nearly 1000 genes has started to uncover how diversity among traits can be traced to differences in patients’ genetic mutations.
- November 12, 2014
During National Alzheimer’s Disease Awareness Month, we look at Scott Small’s newest Alzheimer’s research.
- November 11, 2014
Several CUMC researchers received grants from the NIH's new BRAIN Initiative, a 12-year research program launched last year by President Obama.
- October 26, 2014
Dietary cocoa flavanols—naturally occurring bioactives found in cocoa—reversed age-related memory decline in healthy older adults, according to a study led by CUMC scientists.